CTOs on the Move

Inversago Pharma

www.inversago.com

 
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.inversago.com
  • 1 Place Ville-Marie Suite 1670
    Montreal, QC CAN H3B 2B6
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Inversago Pharma raised $35M on 09/08/2020

Similar Companies

QoL Meds

QoL Meds is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corza Medical

Let’s operate. We prioritize you, so you can prioritize patients. Trusted brands like Quill, Sharpoint, and Tachosil.

Draximage

Draximage is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SCA Pharma

SCA Pharma is a leading FDA 503B outsourcing facility delivering the highest quality sterile admixtures and pre-filled syringes to hospitals and health systems nationwide. SCA Pharma prides itself on being the most customer- and patient-focused 503B in the industry. Known for its unwavering quality and high-touch customer service, SCA Pharma is headquartered in Little Rock, AR with a sister facility in Windsor, CT. The Windsor facility boasts more than 90,000 square feet of sterile compounding laboratory and manufacturing space while Little Rock is home to SCA Pharma`s 17,000 square foot sterile compounding facility. Both facilities meet or exceed FDA cGMP manufacturing guidelines. SCA Pharma employs more than 500 people across both facilities, as well as a team of sales representatives across the country.